Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-10

Clinical Trial Update: A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo [Phase 2]

View source ↗

Summary

Phase 2 trial of INCB018424 phosphate cream in vitiligo has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INCB018424 phosphate cream (ruxolitinib phosphate cream)

Snippet

Sponsor: Incyte Corporation | Conditions: Vitiligo | Phase 2 | Status: COMPLETED | Results posted: 2021-12-10